Venture capitalists are taking exception to recent comments by Food and Drug Administration Commissioner Margaret Hamburg, who said in an Aug. 1 Wall Street Journal guest column that the agency’s cautious approach to approving new medical treatments boosts consumer confidence in products on the market, and stimulates economic growth.
Investors in emerging medical technologies, who say that a number of start-up companies have either gone out of business or moved overseas because of delays and uncertainty at the FDA, say the agency’s caution has given way to overzealousness, and that it is now next to impossible to get new devices or drugs approved in a timely manner.
To read the full, original article click on this link: VCs Ramp Up Pressure On FDA Over Medical Device Approvals - Venture Capital Dispatch - WSJ
Author:
Timothy Hay
